Biotransform solutions use the first commercial software to automate protein catabolite identification and speeds identification of metabolites and catabolites. FRAMINGHAM, Mass.–SCIEX, a global leader in life science analytical technologies, announced today the latest additions to its growing line of solutions for pharmaceutical drug discovery and development. The Routine Biotransform Solution and the Advanced Biotransform Solution […]

Harderwijk, the Netherlands and El Segundo, CA, USA – March 29, 2017 – GENALICE and BioDiscovery announce a co-marketing partnership to offer their products together as a turn-key end-to-end solution for the use of next-generation sequencing (NGS) data to interpret genomes. GENALICE provides an ultra-fast and highly accurate secondary analysis suite that seamlessly connects to […]

New Service Combines Powerful Technology with Medical and Scientific Expertise PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today at annual ACMG Clinical Genetics Meeting in Phoenix that it has launched clinical interpretation services as a part of its entire Next Generation Sequencing (NGS) service portfolio. The new service represents PierianDx’s continued […]

OAKLAND, Calif. & DANVERS, Mass. & PHOENIX– Fabric Genomics, a global computational genomics company, and Veritas Genetics, the global leader in genetic sequencing and interpretation, announced today at the ACMG Annual Clinical Genetics Meeting that they have entered into a technology partnership. The goal of the collaboration is to accelerate Veritas’ myGenome product for personal […]

OAKLAND, Calif. & PHOENIX Omicia today announced that it has rebranded and renamed the organization to better reflect the company’s ability to uniquely deliver clinical quality genomic data insights. Now known as Fabric Genomics TM, the company revealed its new name, logo and brand identity at this week’s ACMG Annual Clinical Genetics Meeting. The company […]

Fabric Genomics, a global computational genomics company, and Sentieon, which develops highly optimized algorithms for bioinformatics applications, today announced a technology partnership that will enhance Fabric Genomics’ secondary analysis capabilities within Fabric EnterpriseTM, the company’s new end-to-end precision medicine platform. Fabric Genomics’ new secondary analysis offering, Fabric StandardTM, is 10 times faster than commonly adopted BWA-GATK […]

Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage of genomic data. […]

Product Extends the Functionality of Progenesis QI for Proteomics Applications MILFORD, Mass.– Waters Corporation (NYSE:WAT) announced that it will now offer Proteolabels, a new software that has been designed as an extension for Progenesis® QI for proteomics users and researchers. Proteolabels supports studies involving stable isotope labels, such as “SILAC” and dimethyl labeling in duplex or triplex. Waters® is offering Proteolabels through an […]

Leading Experts in Genomic Medicine and Cancer Research are Inaugural Members CAMBRIDGE, Mass. – Seven Bridges, the biomedical data analysis company, today announced its Scientific Advisory Board, which formalizes relationships with leading global experts in genomic medicine, bioinformatics and cancer research. Members of the Seven Bridges Scientific Advisory Board will advise on the company’s product designs […]

Sophia Genetics reports adoption of its AI SOPHiA by over 250 health institutions in 45 countries By the end of Q1 2017, the company will cross the strategic threshold of 100K patients’ genomic profiles analyzed by its artificial intelligence Strategic milestones underline SOPHiA’s traction and confirm it is now clinicians’ technology of choice for analyzing […]